Bamco Inc Revance Therapeutics, Inc. Transaction History

Bamco Inc

$36.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$5.81 - $11.2 $19,922 - $38,404	3,429 Added 0.34%	1,023,663 $9 Million
Q3 2023 Nov 14, 2023	SELL	$11.47 - $25.07 $1.17 Million - $2.57 Million	-102,432 Reduced 9.12%	1,020,234 $11.7 Million
Q2 2023 Aug 14, 2023	BUY	$24.7 - $37.61 $1.31 Million - $2 Million	53,183 Added 4.97%	1,122,666 $28.4 Million
Q1 2023 May 15, 2023	SELL	$18.36 - $35.27 $3.46 Million - $6.64 Million	-188,225 Reduced 14.97%	1,069,483 $34.4 Million
Q4 2022 Feb 14, 2023	SELL	$18.32 - $30.66 $8.48 Million - $14.2 Million	-462,800 Reduced 26.9%	1,257,708 $23.2 Million
Q3 2022 Nov 14, 2022	BUY	$14.33 - $28.47 $537,375 - $1.07 Million	37,500 Added 2.23%	1,720,508 $46.5 Million
Q2 2022 Aug 15, 2022	BUY	$11.52 - $20.4 $3.35 Million - $5.93 Million	290,600 Added 20.87%	1,683,008 $23.3 Million
Q3 2021 Nov 12, 2021	BUY	$25.78 - $33.21 $6.66 Million - $8.58 Million	258,476 Added 22.79%	1,392,408 $38.8 Million
Q2 2021 Aug 13, 2021	BUY	$26.8 - $31.84 $1.13 Million - $1.34 Million	42,200 Added 3.87%	1,133,932 $33.6 Million
Q1 2021 May 19, 2021	BUY	$24.03 - $29.97 $8.41 Million - $10.5 Million	350,000 Added 47.19%	1,091,732 $30.5 Million
Q4 2020 Feb 12, 2021	BUY	$23.41 - $28.34 $3.75 Million - $4.53 Million	160,000 Added 27.5%	741,732 $21 Million
Q2 2020 Aug 14, 2020	BUY	$12.6 - $26.55 $945,000 - $1.99 Million	75,000 Added 14.8%	581,732 $14.2 Million
Q1 2020 May 15, 2020	SELL	$12.46 - $27.81 $4 Million - $8.93 Million	-321,000 Reduced 38.78%	506,732 $7.5 Million
Q3 2019 Nov 14, 2019	BUY	$10.22 - $14.5 $1.97 Million - $2.79 Million	192,532 Added 30.31%	827,732 $10.8 Million
Q2 2019 Aug 15, 2019	BUY	$10.67 - $15.49 $1.34 Million - $1.95 Million	126,000 Added 24.74%	635,200 $8.24 Million
Q1 2019 May 15, 2019	BUY	$15.4 - $20.39 $7.84 Million - $10.4 Million	509,200 New	509,200 $8.03 Million

Others Institutions Holding RVNC

# of Institutions

234

Shares Held

82.8M

Call Options Held

680K

Put Options Held

896K

Black Rock Inc. New York, NY

8.57M
Shares

$22 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

5.73M
Shares

$14.7 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

4.78M
Shares

$12.3 Million
0.0% of portfolio
Fil LTD Hamilton, D0

4.19M
Shares

$10.8 Million
0.01% of portfolio
Alpine Associates Management Inc. Englewood Cliffs, NJ

4.16M
Shares

$10.7 Million
0.49% of portfolio

View Full List

About Revance Therapeutics, Inc.

Ticker RVNC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,305,696
Market Cap $212M
Description
Revance Therapeutics, Inc., a biotechnology company, engages in the development, manufacture, and commercialization of neuromodulators for various aesthetic and therapeutic indications in the United States and internationally. The company's lead drug candidate is DaxibotulinumtoxinA for injection, which has completed phase III clinical trials fo...

More about RVNC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

News

Stay updated on Bamco Inc with notifications on news.

Account